Tumor-Propagating Cells Don’t Work Alone
While using zebrafish for their research, a newly published study from Massachusetts General Hospital suggests that tumor-propagating cells aren’t always the first colonizing cells that…
While using zebrafish for their research, a newly published study from Massachusetts General Hospital suggests that tumor-propagating cells aren’t always the first colonizing cells that…
Newly published research from biochemists at the University of North Carolina School of Medicine describes how a protein that is required for DNA replication, Cdt1,…
A new study from MIT shows that staggering the delivery of cancer drugs is far more effective than administering them at the same time. The…
A new study describes how a team of researchers is exploring ways to manipulate the body’s existing T cells that normally kill viruses and redirect…
New research indicates that there could be a single drug that could shrink or cure all types of cancer, whether it’s breast, ovary, colon, bladder,…
The cancer drug, BIND-014, is the first targeted and programmed nanomedicine to enter human clinical studies. A newly published study demonstrate BIND-014’s ability to effectively…
A new vaccine has been found to extend the life of patients suffering from recurrent glioblastoma multiforme. A phase 2 clinical trial showed that by…
Technological advances in the field of neutron generators are being made at Sandia National Laboratory. By thinking outside the box, scientists have come up with…
A newly published research study from the UNC Lineberger Comprehensive Cancer Center describes how the absence of the protein NLRP12 significantly increases susceptibility to colitis-associated…
A new study suggests that dosage size matters when it comes to treating cancer with angiogenesis inhibitors and nanomedicines. Scientists at the Harvard School of…
Findings suggest that our own immune system may be working against us when it comes to protection from skin cancer. The scientists found that in…
Authored by leading scientists at top institutions, the Cancer Cell Line Encyclopedia (CCLE) is a resource that joins deeply detailed cancer genome data with predictors…
Zelboraf, which targets the mutated BRAF gene, is used to treat melanoma, but it isn’t always successful due to melanoma’s ability to sometimes get around…
A new study identified the protein phosphatase SHP2 as an important player in the signaling cascades governing tumor-initiating cells. The scientists found that SHP2 plays…
A computational epigenetics research group at the Max Planck Institute for Informatics in Saarbrücken is using software programs to rummage through the genomes of cancer…
New research shows that the approved drug Zelboraf nearly doubles the median survival time for patients with metastatic melanoma. By following 132 patients, researchers found…
Researchers at MIT and Massachusetts General Hospital have demonstrated a new microfluidic device that can isolate target cells much faster than existing devices and may…
While observing breast cancer cells in culture, researchers at Cornell University identified two key proteins, Hsp70 and tTG, that are responsible for cell migration. By…